Consultation Psychiatry in COVID-19 Patients: Lopinavir/ritonavir Interactions with Main Psychiatric Drugs
Overview
Overview
Journal
Psychiatry Clin Neurosci
Specialties
Neurology
Psychiatry
Psychiatry
Date
2021 Jan 29
PMID
33511703
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions.
Lim S, Al Bishtawi B, Lim W Eur J Drug Metab Pharmacokinet. 2023; 48(3):221-240.
PMID: 37093458 PMC: 10123480. DOI: 10.1007/s13318-023-00826-8.
Czech B, Krzyszczak A, Boguszewska-Czubara A, Opielak G, Josko I, Hojamberdiev M Sci Total Environ. 2022; 824:153967.
PMID: 35182634 PMC: 8849850. DOI: 10.1016/j.scitotenv.2022.153967.
References
1.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G
. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799.
PMC: 7121492.
DOI: 10.1056/NEJMoa2001282.
View
2.
Bates D, Herman R
. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir. Ann Pharmacother. 2006; 40(6):1190-5.
DOI: 10.1345/aph.1G630.
View
3.
Piscitelli S, Burstein A, Chaitt D, Alfaro R, Falloon J
. Indinavir concentrations and St John's wort. Lancet. 2000; 355(9203):547-8.
DOI: 10.1016/S0140-6736(99)05712-8.
View
4.
Kim R
. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab Rev. 2002; 34(1-2):47-54.
DOI: 10.1081/dmr-120001389.
View
5.
Hill L, Lee K
. Pharmacotherapy considerations in patients with HIV and psychiatric disorders: focus on antidepressants and antipsychotics. Ann Pharmacother. 2013; 47(1):75-89.
DOI: 10.1345/aph.1R343.
View